WavelinQ

In the U.S. alone, there are more than 440,000 patients with End-Stage Renal Disease (ESRD) who are surviving on hemodialysis.[i] The BD WavelinQ™ 4F endoAVF system provides clinicians with a minimally invasive AVF creation alternative to open surgery. The BD WavelinQ™ 4F endoAVF system, with its slim profile, increases the anatomical AVF location options and enables additional venous wrist access points (ulnar vein or radial vein), providing increased procedural flexibility for physicians while reducing risk of scarring or arm disfigurement for patients compared to open surgical AV fistula creation.

When patients have ESRD, their kidneys can no longer keep up with the body’s need to remove extra waste and water. Once kidney function goes below 10-15 percent of normal function, hemodialysis treatments, which are often achieved with an AV fistula, or a kidney transplant are necessary to sustain life.

People living with ESRD are an underserved patient population with very limited treatment options available to them. We’re excited to add BD WavelinQ 4F endoAVF system to our portfolio of technologies that create, restore and/or maintain AV access for patients on hemodialysis.

As Seen on

Contact Our Office


MedNet Technologies
© 2019 Minimally Invasive Vascular Center and MedNet Technologies, Inc. MedNet-Sites All Rights Reserved.